These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25173695)

  • 1. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders.
    Chan MK; Gottschalk MG; Haenisch F; Tomasik J; Ruland T; Rahmoune H; Guest PC; Bahn S
    Prog Neurobiol; 2014 Nov; 122():45-72. PubMed ID: 25173695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biomarker research in neuropsychiatry: challenges and potential].
    Gottschalk MG; Schwarz E; Bahn S
    Fortschr Neurol Psychiatr; 2013 May; 81(5):243-9. PubMed ID: 23695789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain through the retina: the flash electroretinogram as a tool to investigate psychiatric disorders.
    Lavoie J; Maziade M; Hébert M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():129-34. PubMed ID: 24121062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review.
    Pinto JV; Moulin TC; Amaral OB
    Neurosci Biobehav Rev; 2017 Dec; 83():97-108. PubMed ID: 28986182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging-aided differential diagnosis of the depressive state.
    Takizawa R; Fukuda M; Kawasaki S; Kasai K; Mimura M; Pu S; Noda T; Niwa S; Okazaki Y;
    Neuroimage; 2014 Jan; 85 Pt 1():498-507. PubMed ID: 23764293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurable outcomes in psychiatric disorders: remission as a marker of wellness.
    McIntyre RS; Fallu A; Konarski JZ
    Clin Ther; 2006 Nov; 28(11):1882-91. PubMed ID: 17213009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders.
    Schwarz E; Bahn S
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S133-6. PubMed ID: 18193070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker identification in psychiatric disorders: from neuroscience to clinical practice.
    Razafsha M; Khaku A; Azari H; Alawieh A; Behforuzi H; Fadlallah B; Kobeissy FH; Wang KK; Gold MS
    J Psychiatr Pract; 2015 Jan; 21(1):37-48. PubMed ID: 25603450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.
    Papolos D; Mattis S; Golshan S; Molay F
    J Affect Disord; 2009 Nov; 118(1-3):28-38. PubMed ID: 19631388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.
    Patel S
    Expert Rev Proteomics; 2012 Jun; 9(3):249-65. PubMed ID: 22809205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Biomarkers in Psychiatry.
    Lozupone M; La Montagna M; D'Urso F; Daniele A; Greco A; Seripa D; Logroscino G; Bellomo A; Panza F
    Adv Exp Med Biol; 2019; 1118():135-162. PubMed ID: 30747421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteomics for investigating psychiatric disorders.
    Filiou MD; Turck CW; Martins-de-Souza D
    Proteomics Clin Appl; 2011 Feb; 5(1-2):38-49. PubMed ID: 21280236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimensional approaches to psychiatric diagnosis in DSM-5.
    Narrow WE; Kuhl EA
    J Ment Health Policy Econ; 2011 Dec; 14(4):197-200. PubMed ID: 22345361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of serum biomarkers for major psychiatric disorders.
    van Beveren NJ; Hoogendijk WJ
    Int Rev Neurobiol; 2011; 101():351-74. PubMed ID: 22050859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Dec; 34(6):597-605. PubMed ID: 19081457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How biomarkers will change psychiatry. Part II: Biomarker selection and potential inflammatory markers of depression.
    Macaluso M; Drevets WC; Preskorn SH
    J Psychiatr Pract; 2012 Jul; 18(4):281-6. PubMed ID: 22805902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Roles of brain science in psychiatry].
    Ito M
    Seishin Shinkeigaku Zasshi; 2002; 104(11):1005-16. PubMed ID: 12642905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.